On July 18th, news surfaced that OpenEvidence, a medical artificial intelligence (AI) startup often dubbed the 'ChatGPT for the Medical Field' (or more specifically tailored as 'ChatGPT for Doctors'), is gearing up for a fresh round of financing. Owing to its remarkable achievements in clinical decision support and medical data analysis, external venture capital firms are now eyeing the company with a valuation that could reach a staggering $20 billion, vying fiercely for a slice of the investment pie.
